S9562 HCPCS code: Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

S9562 is the HCPCS Level II code for home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.

Code details

FieldValue
SectionS codes — Temporary national codes (non-Medicare)
Coverage codeI — Not payable by Medicare
Pricing indicator00 — Not separately priced by Medicare
BETOS categoryZ2
Added2003-01-01
Last action effective2023-04-01

What changed for S9562

Frequently asked questions

What is HCPCS code S9562?

S9562 is the HCPCS Level II code for home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. Short descriptor: "Ht inj palivizumab/ab diem".

Does Medicare cover S9562?

Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.

Related S95 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All S codes · HCPCS lookup